Literature DB >> 8067755

Susceptibility testing of Dientamoeba fragilis ATCC 30948 with iodoquinol, paromomycin, tetracycline, and metronidazole.

F T Chan1, M X Guan, A M Mackenzie, F Diaz-Mitoma.   

Abstract

Susceptibility testing was performed on Dientamoeba fragilis ATCC 30948 in a dixenic culture with Klebsiella pneumoniae and Bacteroides vulgatus. D. fragilis was cocultured with the bacteria in TYGM-9 medium (ATCC medium 1171). The activities of antiparasitic drugs were assessed by counting viable D. fragilis trophozoites with a hemacytometer by trypan blue exclusion. The minimal amebicidal concentrations of the following four drugs were determined: iodoquinol at 128 micrograms/ml, paromomycin at 16 micrograms/ml, tetracycline (questionably) at 32 micrograms/ml, and metronidazole at 32 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8067755      PMCID: PMC188168          DOI: 10.1128/AAC.38.5.1157

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  18 in total

1.  Enterobius vermicularis as a probable vector of Dientamoeba fragilis.

Authors:  R B BURROWS; M A SWERDLOW
Journal:  Am J Trop Med Hyg       Date:  1956-03       Impact factor: 2.345

2.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

3.  Dientamoeba fragilis in human feces and bile.

Authors:  B Talis; B Stein; J Lengy
Journal:  Isr J Med Sci       Date:  1971-09

4.  Entamoeba histolytica and Dientamoeba fragilis and the syndrome of chronic recurrent intestinal amoebiasis in Israel.

Authors:  H Steinitz; B Talis; B Stein
Journal:  Digestion       Date:  1970       Impact factor: 3.216

5.  A newly revised classification of the protozoa.

Authors:  N D Levine; J O Corliss; F E Cox; G Deroux; J Grain; B M Honigberg; G F Leedale; A R Loeblich; J Lom; D Lynn; E G Merinfeld; F C Page; G Poljansky; V Sprague; J Vavra; F G Wallace
Journal:  J Protozool       Date:  1980-02

6.  The neglected ameba: dientamoeba fragilis. A report of 100 "pure" infections.

Authors:  B H Kean; C L Malloch
Journal:  Am J Dig Dis       Date:  1966-09

7.  Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile.

Authors:  R P Bolton; M A Culshaw
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

8.  Dientamoeba fragilis: a review with notes on its epidemiology, pathogenicity, mode of transmission, and diagnosis.

Authors:  J Yang; T Scholten
Journal:  Am J Trop Med Hyg       Date:  1977-01       Impact factor: 2.345

9.  Dientamoeba fragilis: a gastrointestinal protozoan infection in adults.

Authors:  M J Spencer; M R Chapin; L S Garcia
Journal:  Am J Gastroenterol       Date:  1982-08       Impact factor: 10.864

10.  Dientamoeba fragilis, a protozoan parasite in adult members of a semicommunal group.

Authors:  V Millet; M J Spencer; M Chapin; M Stewart; J A Yatabe; T Brewer; L S Garcia
Journal:  Dig Dis Sci       Date:  1983-04       Impact factor: 3.199

View more
  9 in total

1.  Prevalence of Dientamoeba fragilis antibodies in children and recognition of a 39 kDa immunodominant protein antigen of the organism.

Authors:  F Chan; N Stewart; M Guan; I Robb; L Fuite; I Chan; F Diaz-Mitoma; J King; N MacDonald; A Mackenzie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

Review 2.  Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.

Authors:  Damien Stark; Joel Barratt; Douglas Chan; John T Ellis
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

3.  Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples.

Authors:  D Stark; J Barratt; T Roberts; D Marriott; J Harkness; J Ellis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-14       Impact factor: 3.267

4.  In vitro susceptibility testing of Dientamoeba fragilis.

Authors:  N Nagata; D Marriott; J Harkness; J T Ellis; D Stark
Journal:  Antimicrob Agents Chemother       Date:  2011-10-24       Impact factor: 5.191

Review 5.  Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis.

Authors:  Eugene H Johnson; Jeffrey J Windsor; C Graham Clark
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

Review 6.  Current treatment options for Dientamoeba fragilis infections.

Authors:  Noriyuki Nagata; Deborah Marriott; John Harkness; John T Ellis; Damien Stark
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-09-03       Impact factor: 4.077

7.  Activity of benzimidazoles against Dientamoeba fragilis (Trichomonadida, Monocercomonadidae) in vitro and correlation of beta-tubulin sequences as an indicator of resistance.

Authors:  Damien Stark; Joel L N Barratt; Tamalee Roberts; Deborah Marriott; John T Harkness; John Ellis
Journal:  Parasite       Date:  2014-08-25       Impact factor: 3.000

8.  Repositioning of 8-hydroxyquinoline derivatives as a new promising candidate for combating multidrug resistant Neisseria gonorrhoeae.

Authors:  Ratana Lawung; Rungrot Cherdtrakulkiat; Sunanta Nabu; Supaluk Prachayasittikul; Chartchalerm Isarankura-Na-Ayudhya; Virapong Prachayasittikul
Journal:  EXCLI J       Date:  2018-08-23       Impact factor: 4.068

9.  Paromomycin is superior to metronidazole in Dientamoeba fragilis treatment.

Authors:  Ander Burgaña; Rosa Abellana; Stanislav Zlatanov Yordanov; Rabee Kazan; A Mauricio Pérez Ortiz; Cristina Castillo Ramos; Christian Garavito Hernández; Miriam Molina Rivero; Alessandra Queiroga Gonçalves; Emma Padilla; Josefa Pérez; Roger García-Puig; Tomas M Perez-Porcuna
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-11-11       Impact factor: 4.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.